The osmolyte xylitol reduces the salt concentration of airway surface liquid and may enhance bacterial killing

被引:95
作者
Zabner, J
Seiler, MP
Launspach, JL
Karp, PH
Kearney, WR
Look, DC
Smith, JJ
Welsh, MJ
机构
[1] Univ Iowa, Coll Med, Dept Internal Med, Iowa City, IA 52242 USA
[2] Univ Iowa, Coll Med, Howard Hughes Med Inst, Iowa City, IA 52242 USA
[3] Univ Iowa, Coll Med, Dept Pediat, Iowa City, IA 52242 USA
[4] Univ Iowa, Coll Med, Dept Physiol & Biophys, Iowa City, IA 52242 USA
[5] Univ Iowa, Coll Med, Dept Nucl Magnet Resonance Facil, Iowa City, IA 52242 USA
[6] Washington Univ, Dept Med, St Louis, MO 63110 USA
关键词
D O I
10.1073/pnas.97.21.11614
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The thin layer of airway surface liquid (ASL) contains antimicrobial substances that kill the small numbers of bacteria that are constantly being deposited in the lungs. An increase in ASL salt concentration inhibits the activity of airway antimicrobial factors and may partially explain the pathogenesis of cystic fibrosis (CF). We tested the hypothesis that an osmolyte with a low transepithelial permeability may lower the ASL salt concentration. thereby enhancing innate immunity. We found that the five-carbon sugar xylitol has a low transepithelial permeability, is poorly metabolized by several bacteria, and can lower the ASL salt concentration in both CF and non-CF airway epithelia in vitro. Furthermore, in a double-blind, randomized, crossover study, xylitol sprayed for 4 days into each nostril of normal Volunteers significantly decreased the number of nasal coagulase-negative Staphylococcus compared with saline control. Xylitol may be of value in decreasing ASL salt concentration and enhancing the innate antimicrobial defense at the airway surface.
引用
收藏
页码:11614 / 11619
页数:6
相关论文
共 40 条
[1]   Ion composition and rheology of airway liquid from cystic fibrosis fetal tracheal xenografts [J].
Baconnais, S ;
Tirouvanziam, R ;
Zahm, JM ;
de Bentzmann, S ;
Péault, B ;
Balossier, G ;
Puchelle, E .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1999, 20 (04) :605-611
[2]   The innate immune system in cystic fibrosis lung disease [J].
Bals, R ;
Weiner, DJ ;
Wilson, JM .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (03) :303-307
[3]   Human β-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung [J].
Bals, R ;
Wang, XR ;
Wu, ZR ;
Freeman, T ;
Bafna, V ;
Zasloff, M ;
Wilson, JM .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (05) :874-880
[4]   Microbiology of sputum from patients at cystic fibrosis centers in the United States [J].
Burns, JL ;
Emerson, J ;
Stapp, JR ;
Yim, DL ;
Krzewinski, J ;
Louden, L ;
Ramsey, BW ;
Clausen, CR .
CLINICAL INFECTIOUS DISEASES, 1998, 27 (01) :158-163
[5]  
CITRON DM, 1994, BAILEY SCOTTS DIAGNO, P219
[6]  
Cohen J., 1998, Statistical Power Analysis for the Behavioral Sciences, V2nd
[7]   Inhalation of dry powder mannitol improves clearance of mucus in patients with bronchiectasis [J].
Daviskas, E ;
Anderson, SD ;
Eberl, S ;
Chan, HK ;
Bautovich, G .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (06) :1843-1848
[8]   CHARACTERIZATION OF XYLITOL-UTILIZING MUTANTS OF ERWINIA-UREDOVORA [J].
DOTEN, RC ;
MORTLOCK, RP .
JOURNAL OF BACTERIOLOGY, 1985, 161 (02) :529-533
[9]   Sugar substitutes, chewing gum and dental caries - a review [J].
Edgar, WM .
BRITISH DENTAL JOURNAL, 1998, 184 (01) :29-32
[10]   ON THE USE OF ABSORBING DISKS TO SAMPLE MUCOSAL SURFACE LIQUIDS [J].
ERJEFALT, I ;
PERSSON, CGA .
CLINICAL AND EXPERIMENTAL ALLERGY, 1990, 20 (02) :193-197